However, drug-eluting stents may be associated with delayed (or absent) endothelialization, localized hypersensitivity reactions and late stent thrombosis. Stent thrombosis is a catastrophic event ...

Stent thrombosis is a rare but potentially life threatening complication of percutaneous coronary intervention (PCI). It develops when a blood clot blocks blood flow through your stent. A coronary ...

A newly FDA- approved stent designed to grow with the child offers a better option.Oct. 17, 2024 ...

ANGELA STENT is Professor Emerita at Georgetown University and a Nonresident Senior Fellow at the Brookings Institution. From 2004 to 2006, she served as National Intelligence Officer for Russia and ...

The US Food and Drug Administration has approved a heart stent specifically made for infants and young children - a device ...

Bioresorbable stents (BRS) were initially developed with the goal of providing adequate mechanical support and drug delivery in the short to medium term (one to two years) while gradually disappearing ...

Cipla and Alkem Laboratories have emerged as the leading contenders to acquire a controlling stake in Mumbai-based Sahajanand Medical Technologies (SMT), India’s largest cardiac stent manufacturer.

Aims: Coronary artery bypass grafts (CABGs) are increasingly performed in elderly patients. Risk factors and outcomes are poorly described for those undergoing noncardiac surgery within 1 year ...

Currently, the prevention of inflammation is carried out mainly by the local delivery of anti-inflammatory drugs and coating stents with anti-inflammatory drugs (Park and Yoo, 2006; Inoue et al., 2011 ...

Patients Between 2005 and 2012, 52 selected patients underwent percutaneous stent implantation into a very narrow RVOT to improve pulmonary blood flow. Median age at stent implantation was 63 (range 4 ...